EXPRES2ION Financial Statements From 2010 to 2024
| 5JD Stock | EUR 1.83 0.06 3.39% |
Check EXPRES2ION BIOTECH financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXPRES2ION BIOTECH's main balance sheet or income statement drivers, such as , as well as many indicators such as . EXPRES2ION financial statements analysis is a perfect complement when working with EXPRES2ION BIOTECH Valuation or Volatility modules.
EXPRES2ION |
EXPRES2ION BIOTECH HLDG Company Gross Profit Analysis
EXPRES2ION BIOTECH's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current EXPRES2ION BIOTECH Gross Profit | 6.22 M |
Most of EXPRES2ION BIOTECH's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EXPRES2ION BIOTECH HLDG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, EXPRES2ION BIOTECH HLDG reported 6.22 M of gross profit. This is 99.72% lower than that of the Healthcare sector and 99.35% lower than that of the Biotechnology industry. The gross profit for all Germany stocks is 99.98% higher than that of the company.
EXPRES2ION BIOTECH HLDG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EXPRES2ION BIOTECH's current stock value. Our valuation model uses many indicators to compare EXPRES2ION BIOTECH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EXPRES2ION BIOTECH competition to find correlations between indicators driving EXPRES2ION BIOTECH's intrinsic value. More Info.EXPRES2ION BIOTECH HLDG is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EXPRES2ION BIOTECH's earnings, one of the primary drivers of an investment's value.About EXPRES2ION BIOTECH Financial Statements
EXPRES2ION BIOTECH stakeholders use historical fundamental indicators, such as EXPRES2ION BIOTECH's revenue or net income, to determine how well the company is positioned to perform in the future. Although EXPRES2ION BIOTECH investors may analyze each financial statement separately, they are all interrelated. For example, changes in EXPRES2ION BIOTECH's assets and liabilities are reflected in the revenues and expenses on EXPRES2ION BIOTECH's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in EXPRES2ION BIOTECH HLDG. Please read more on our technical analysis and fundamental analysis pages.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. EXPRES2ION BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 17 people.
Currently Active Assets on Macroaxis
Other Information on Investing in EXPRES2ION Stock
EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.